| Trial ID: | L6019 |
| Source ID: | NCT00573950
|
| Associated Drug: |
Cilostazol
|
| Title: |
Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Metabolic Syndrome X
|
| Interventions: |
DRUG: cilostazol|DRUG: Placebo
|
| Outcome Measures: |
Primary: The effect on pulse wave velocity (PWV), 8 weeks | Secondary: the effect on atherosclerotic and inflammatory markers such as adiponectin, hsCRP, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: Korea University Anam Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-12
|
| Completion Date: |
2008-12
|
| Results First Posted: |
|
| Last Update Posted: |
2007-12-14
|
| Locations: |
Korea Univerisity Anam Hospital, Seoul, 136-705, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00573950
|
